Published in Qual Life Res on April 01, 2006
Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health Qual Life Outcomes (2007) 1.40
Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device). Health Qual Life Outcomes (2009) 1.35
A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas (2013) 1.25
Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health Qual Life Outcomes (2007) 1.12
What can we learn from patient-reported outcomes of insulin pen devices? J Diabetes Sci Technol (2011) 1.04
Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire. Health Qual Life Outcomes (2007) 0.97
Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study. Int J Clin Pract (2009) 0.93
Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study. Int J Clin Pract (2009) 0.88
Glycemic variability: Clinical implications. Indian J Endocrinol Metab (2013) 0.87
Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors. Qual Life Res (2010) 0.87
Hypoglycaemic events in patients with type 2 diabetes in the United Kingdom: associations with patient-reported outcomes and self-reported HbA1c. BMC Endocr Disord (2013) 0.86
Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities. Patient (2014) 0.83
Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan. World J Diabetes (2015) 0.81
Patients' satisfaction with diabetes medications in one hospital, Saudi Arabia. Patient Prefer Adherence (2012) 0.78
Glucose control and fatigue in type 2 diabetes: the mediating roles of diabetes symptoms and distress. J Adv Nurs (2015) 0.77
Evolving trends in insulin delivery in pursuit of improvements in diabetes management. Am Health Drug Benefits (2010) 0.77
Once-weekly albiglutide in the management of type 2 diabetes: patient considerations. Patient Prefer Adherence (2014) 0.76
The complex interplay between clinical and person-centered diabetes outcomes in the two genders. Health Qual Life Outcomes (2017) 0.75
Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care (2005) 5.99
Economic costs of overactive bladder in the United States. Urology (2009) 2.68
Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther (2004) 1.62
Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes (2004) 1.48
Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures. Diabetes Care (2008) 1.47
Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res (2006) 1.17
Epidemiology and correlates of weight worry in the multinational Diabetes Attitudes, Wishes and Needs study. Curr Med Res Opin (2009) 1.12
Impact of estradiol-valerate/dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding. Int J Womens Health (2012) 0.84
Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials. Curr Med Res Opin (2004) 0.82
Parent and health professional perspectives in the management of adolescents with diabetes: development of assessment instruments for international studies. Qual Life Res (2006) 0.79
Impact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding. J Womens Health (Larchmt) (2013) 0.78
Potential economic impact of increasing low dose aspirin usage on CVD in the US. Curr Med Res Opin (2010) 0.76
[Erroneous use of the "EuroQol" indication for quality measurement in Ugeskriftet]. Ugeskr Laeger (2006) 0.75